Citalopram USP Related Compound E

IMPURITIES

Purchase Online > Select Pack Size Note: 5% Discount applied

This product can be shipped immediately on placing an online order.

CAT No.# CS-I-00028
Category Impurities
CAS 63284-72-0
Stock Status
IN-STOCK HAVE QUESTIONS ?
Molecular Weight 340.3913
Molecular Formula C20H21FN2O2
Purity: >98%
Synonyms: Citalopram USP Related Compound E;3-(5-cyano-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-1-yl)-N,N-dimethylpropan-1-amine oxide;3-(5-cyano-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-1-yl)-N,N-dimethylpropan-1-amine oxide; Citalopram N-oxide
Application Notes: Impurity in commercial preparations of Citalopram
References: Nemeroff, CB (2012);Cohen, D (2007)
Shipping: Free Shipping for worldwide on order above 2000 USD
Citalopram USP Related Compound E Worldwide Suppliers of Citalopram USP Related Compound E Impurities Clearsynth CS-I-00028

Product rating: 9 Citalopram USP Related Compound E based on 20 ratings

  1. Impurities
  2. Citalopram USP Related Compound E


PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Riluzole (1604337)
15. Pheniramine impurity B
16. Palbociclib N-Glucuronide
17. Carpropamid
18. Olmesartan N1-Trityl Impurity
19. Aripiprazole (1042634)
20. 2-(p-Tolyl)pyrimidine
Smileys:
C[N](CCCC1(C2=CC=C(F)C=C2)C(C=CC(C#N)=C3)=C3CO1)(C)=O



This page contains information about Citalopram USP Related Compound E Cas 63284-72-0 and its Impurities.

Citalopram USP Related Compound E Citalopram USP Related Compound E Worldwide Suppliers of Citalopram USP Related Compound E Impurities Clearsynth 63284-72-0

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."